Management Consulting
PwC
Full Credential Description
The case study highlights the challenges faced by a global biopharma company and a top 15 pharmaceutical organization in the realm of clinical trials. The primary issues included high patient burden, lengthy enrollment durations, and a significant number of avoidable protocol amendments, which collectively increased costs and delayed trial timelines. To address these challenges, PwC implemented its Intelligent Clinical Trials solution, which leverages AI-driven insights to streamline protocol design. This solution enabled the biopharma company to refine its trial protocols, resulting in a 15% reduction in patient burden and a two-month decrease in enrollment duration. These enhancements led to substantial cost savings of approximately $2 million. For the top 15 pharma organization, the deployment of the Intelligent Clinical Trials solution across more than 30 indications resulted in a 25% reduction in avoidable amendments, translating to savings between $2 million and $5 million per trial. Additionally, a top 5 pharma client utilizing the solution for oncology protocols experienced a 10% reduction in patient burden, yielding savings of $5 million to $10 million per trial. Overall,